The Indispensable Nasal Decongestant: Patients’ Views and Perspectives on Nasal Decongestant Overuse
Rhinitis medicamentosa (RM) is a type of nonallergic rhinitis caused by prolonged use of nasal decongestants (NDs). Although it is a preventable phenotype of rhinitis, little is known about patients dealing with this condition.To gain a better understanding of patients' views and experiences of ND overuse, and potential facilitators and barriers to ...
Sophie Scheire +6 more
openaire +2 more sources
Long-acting topical decongestants
Significant role of getting the required amount of air into the human body belongs to the breathing by the nose. The nasal cavity prepares the air for reciprocity with the lower respiratory tract owing to the complex structure of the mucous membrane ...
A. Yu. Ovchinnikov +3 more
doaj +1 more source
Update on the efficiency and safety of orally administered nasal decongestants [PDF]
Nasal congestion leading to obstruction is one of the main symptoms in acute rhinosinusitis (common cold), other upper respiratory infections and allergic rhinitis. The EPOS 2020 guidelines place oral decongestants as an efficient therapy for the relief
Victoria Arama +4 more
doaj +1 more source
CURRENT ASPECTS OF USE OF NASAL VASOCONSTRICTORS AND ADJUNCTIVE AGENTS IN PEDIATRIC PRACTICE
Nasal forms of vasoconstrictor agents (decongestants) are one of the most frequently prescribed groups of drugs in the therapy of inflammatory diseases of the nasal cavity.
D. A. Tulupov +3 more
doaj +1 more source
Management of hypertrophic rhinitis by application of Kadali kshara: An observation
Nasal obstruction is a predominant symptom in hypertrophied inferior turbinate. It can be understood as Nasanaha (~nasal obstruction) in Ayurveda. Even though there are many conditions of the nose causing nasal blockage; inferior turbinate hypertrophy ...
A. Anjali, K. Sivabalaji, B. N. Ashwini
doaj +1 more source
Chinese Guidelines for Diagnosis and Treatment of Chronic Rhinosinusitis (2024). [PDF]
ABSTRACT Chronic rhinosinusitis (CRS), a complex inflammatory disease with heterogeneous pathogenesis, demands evolving evidence‐based strategies. Since the 2018 Chinese guidelines and EPOS2020, international advances in CRS immunopathology and biologics have revolutionized therapeutic approaches, particularly through phenotype–endotype classification ...
Subspecialty Group of Rhinology +4 more
europepmc +2 more sources
Cochrane acute respiratory infections group's stakeholder engagement project identified systematic review priority areas [PDF]
Objective: Cochrane acute respiratory infections (ARIs) group conducts systematic reviews of the evidence for treatment and prevention of ARIs. We report the results of a prioritization project, aiming to identify highest priority systematic review ...
Clark, Justin +5 more
core +1 more source
Nasal decongestants in Brazil are available without prescription. They are one of the most requested medications in Brazil. The use of nasal decongestants, however, may lead to serious consequences.
Dominik Lenz +3 more
doaj +1 more source
Medication use in pregnancy: a cross-sectional, multinational web-based study [PDF]
Objectives: Intercountry comparability between studies on medication use in pregnancy is difficult due to dissimilarities in study design and methodology. his study aimed to examine patterns and factors associated with medications use in pregnancy from a
Bjornsdottir, I. +17 more
core +5 more sources
Treating acute rhinitis and exacerbations of chronic rhinitis – A role for topical decongestants?
Acute nasal symptoms are troublesome for patients. In addition, these symptoms are encountered frequently by individuals because of common infectious diseases, especially rhinovirus, giving rise to a ‘common cold’.
Robin J. Green +5 more
doaj +1 more source

